or Try an Advanced Search...

    Technical Analysis for COEP - Coeptis Therapeutics Holdings, Inc

    Grade Last Price % Change Price Change
    D 0.19 2.47% 0.00
    COEP closed up 2.47 percent on Friday, November 22, 2024, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical COEP trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Fell Below 50 DMA Bearish 2.47%
    Bollinger Band Squeeze Range Contraction 2.47%
    NR7 Range Contraction 2.47%
    NR7-2 Range Contraction 2.47%
    Narrow Range Bar Range Contraction 2.47%
    BB Squeeze + Lower Band Touch Range Contraction 2.47%
    Older End-of-Day Signals for COEP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 12 hours ago
    50 DMA Resistance about 15 hours ago
    10 DMA Resistance about 16 hours ago
    20 DMA Resistance about 17 hours ago
    Up 5% about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    COEP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Cell Therapy

    Is COEP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development
    Oct 24 Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
    Oct 15 Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy
    Sep 5 Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders
    Aug 8 Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
    Jun 20 Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
    May 30 Coeptis Therapeutics' Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
    See more COEP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.28
    52 Week Low 0.1511
    Average Volume 286,695
    200-Day Moving Average 0.29
    50-Day Moving Average 0.19
    20-Day Moving Average 0.20
    10-Day Moving Average 0.20
    Average True Range 0.02
    RSI (14) 47.64
    ADX 20.02
    +DI 10.22
    -DI 9.73
    Chandelier Exit (Long, 3 ATRs) 0.18
    Chandelier Exit (Short, 3 ATRs) 0.24
    Upper Bollinger Bands 0.21
    Lower Bollinger Band 0.19
    Percent B (%b) 0.24
    BandWidth 11.08
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0017
    Fundamentals Value
    Market Cap 6.64 Million
    Num Shares 34.1 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -0.32
    Price-to-Sales 45.68
    Price-to-Book 3.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.22
    Resistance 3 (R3) 0.22 0.21 0.22
    Resistance 2 (R2) 0.21 0.21 0.21 0.21
    Resistance 1 (R1) 0.20 0.20 0.21 0.20 0.21
    Pivot Point 0.20 0.20 0.20 0.20 0.20
    Support 1 (S1) 0.19 0.19 0.19 0.19 0.18
    Support 2 (S2) 0.18 0.19 0.18 0.18
    Support 3 (S3) 0.17 0.18 0.17
    Support 4 (S4) 0.17